Stephen Walsh

27PUBLICATIONS
176CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsVenereologyMedical infection agents (incl. prions)Otorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).

Stephen Walsh, William O Hahn, Wilton B Williams

|Nov 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.

Urjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener

|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|Apr 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).

Sharon A Riddler, Zoe Moodie, Jesse Clark

|Apr 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.

Leigh H Fisher, Erica Lazarus, Chenchen Yu

|Jun 24, 2024
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.

Stephen R Walsh, Cynthia L Gay, Shelly T Karuna

Pageof 5

Frequent Collaborators

5 joint publications

David Montefiori

4 joint publications

Yehuda Z Cohen

4 joint publications

Zoe Moodie

4 joint publications

Georgia D Tomaras